AMS Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

AMS Capital’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,893	Closed	-$746K	–	48
2018 Q3	$746K	Buy	+9,893	New	+$669K	0.61%	32

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMS Capital's ASXC Position: Q4 2018 in Review

AMS Capital sold out of Asensus Surgical, Inc. (ASXC) in Q4 2018, closing a stake of 9,893 shares — an estimated $746K sold.

AMS Capital first reported a position in ASXC in Q3 2018 and held it in 1 quarter. The position peaked at $746K in Q3 2018. 150 funds tracked by Wall St. Rank hold ASXC as of Q4 2018.

AMS Capital reported no remaining Asensus Surgical, Inc. position as of Q4 2018 after selling out during the quarter.
AMS Capital sold 9,893 Asensus Surgical, Inc. shares in Q4 2018, an estimated $746K.
AMS Capital first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 1 quarter.
AMS Capital's Asensus Surgical, Inc. position peaked at $746K in Q3 2018.
150 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.